ArticleCureus2024
Disseminated Kaposi Sarcoma in a Patient With Hematemesis: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaposi sarcoma (KS) is a soft tissue tumor primarily occurring in immunosuppressed patients and, although it has been described, dissemination of KS is rare. This case involves a patient with acquired immunodeficiency syndrome (AIDS) and biopsy-proven cutaneous KS presenting with hematemesis suspected due to gastrointestinal involvement in whom endoscopy with biopsy was contraindicated due to dual antiplatelet therapy (DAPT) and the hypervascular nature of KS tumors. Alternatively, the diagnosis was made via macroscopic findings on bronchoscopy, which demonstrated neovascular lesions, confirming visceral KS. Treatment of disseminated KS generally consists of a combination of high-activity antiretroviral therapy (HAART) and chemotherapy; however, due to financial concerns, this patient was transferred to the National Institutes of Health (NIH), where he received free systemic chemotherapy. On follow-up less than three months later, he had no further symptoms or pulmonary lesions. This case adds to current knowledge by providing alternative pathways for diagnosis of and treatment strategies for patients with disseminated Kaposi Sarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.